Ex vivo rapamycin generates donor Th2 cells that potently inhibit graft-versus-host disease and graft-versus-tumor effects via an IL-4-dependent mechanism.
All Authors:
Authors
Foley JE, Jung U, Miera A, Borenstein T, Mariotti J, Eckhaus M, Bierer BE, Fowler DH.
Author Profiles:
Persons
Publish Date:
Date
Journal:
Venue / Journal
J Immunol
Additional Journal Information
175(9):5732-43